TECHNETIUM AGENTS FOR REGIONAL CEREBRAL

Brand	Owner	Address	Description
CERETEC	GE HEALTHCARE LIMITED	(Trademarks: 801-4) 901 Main Avenue Norwalk CT 06851	TECHNETIUM AGENTS FOR REGIONAL CEREBRAL BLOOD FLOW SCINTIGRAPHY;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

The invention relates to the use of cyclic Prolyl Glycine ("cyclic PG" or "cPG") and analogs and mimetics thereof, as neuroprotective agents for the treatment and or prevention of neurological disorders including but not limited to cerebral ischemia or cerebral infarction resulting from a range of phenomena, such as thromboembolic or hemorrhagic stroke, cerebral basospasms, hypoglycemia, cardiac arrest, status epilepticus, perinatal asphyxia, anoxia such as from drowning, pulmonary surgery, and cerebral trauma, as well as to the treatment and prevention of chronic neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, and as anticonvulsants.